Want to see NDRA full AI Analyst Report?
ENDRA Life Sciences (NDRA) Income Statement
861 Followers
ENDRA Life Sciences Income Statement
Last quarter (Q2 2026), ENDRA Life Sciences's total revenue was $0.00. In Q2, ENDRA Life Sciences's net income was $159.94K. See ENDRA Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 5.76M | $ 10.82M | $ 10.52M | $ 13.16M | $ 11.50M | |
| Depreciation and Amortization | $ 157.29K | $ 206.17K | $ 275.45K | $ 234.26K | $ 224.41K |
| $ -6.87M | $ -11.30M | $ -9.78M | $ -12.92M | $ -11.01M | |
| $ -5.76M | $ -10.82M | $ -10.52M | $ -13.16M | $ -11.50M | |
| $ -1.26M | $ -690.80K | $ 460.49K | $ -21.53K | $ 267.06K | |
| $ -7.03M | $ -11.51M | $ -10.06M | $ -13.18M | $ -11.23M | |
| $ -7.03M | $ -11.51M | $ -10.06M | $ -13.18M | $ -11.23M | |
| Per Share Metrics | |||||
| Basic EPS | $ -8.93 | $ -10.25 | $ -5.89 | $ -4.57 | $ -5.47 |
| Diluted EPS | $ -8.93 | $ -10.25 | $ -5.89 | $ -6.84 | $ -5.47 |
| Weighted Average Shares Outstanding | 787.02K | 1.12M | 1.71M | 1.93M | 2.05M |
| Weighted Average Shares Outstanding (Diluted) | 787.02K | 1.12M | 1.71M | 1.93M | 2.05M |
Currency in USD
